This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
The biotechnology product company reported last month second-quarter earnings of $25.8 million, or 70 cents a share, down from year-earlier earnings of $26.5 million, or 72 cents.
"If industry conditions were to begin showing signs of firming or the stock were to pullback appreciably, we would consider revisiting our rating on this extremely well run business with an extraordinary financial model," Craig-Hallum analysts wrote in a Feb. 1 report.
Forward Annual Dividend Yield: 1.7%
Rated "B (Buy)" by TheStreet Ratings: The company's second-quarter gross profit margin decreased from the prior year.
Techne is extremely liquid. Its Quick Ratio is 12.20, which shows it can meet its short-term cash needs.
In the second quarter, stockholders' net worth increased 10.25% from the previous year.
TheStreet Ratings' price target is
$78.71. The stock closed Monday at $66.13. It has decreased 3.12% year to date.
>>To see these stocks in action, visit the
10 Ex-Dividend Stocks With Buy Ratings portfolio on Stockpickr.
-- Written by Alexandra Zendrian
>To contact the writer of this article, click here:
>To submit a news tip, send an email to:
>To follow the writer on Twitter, go to